EFPIA Newsletter 01 October 2020

Interactive Quiz on the EFPIA Code     #EFPIACode   The EFPIA Code sets the rules guaranteeing that our activities are conducted according to strict ethical principles of professionalism and responsibility. Do these rules apply with no exceptions? Test your knowledge with us! #QuestionsInspireSolutions Read more →

Statements     30 September 2020 The principles of a European Cancer Dashboard: Cancer policy stakeholders converge What gets measured gets done Read more →         28 September 2020 COVID threat must inject urgency into trade talks, say UK & EU pharma bodies The UK and EU pharmaceutical industry are today jointly asking the UK Government and the European Commission to prioritise... Read more →

Blogs     28 September 2020 Introducing the new report “Benefits beyond the EU Falsified Medicines Directive - The hospital... Having the chance to visit hospitals that had implemented the EU FMD, provided valuable first-hand insights into the... Read more →

Videos

	Working together for patients, with patients The EFPIA Code constitutes the collection of ethical rules agreed by EFPIA members for the Promotion of Medicinal Products to healthcare professionals and the interactions with healthcare and patients' organisations, with the intent of guaranteeing that these activities are conducted while respecting the most stringent ethical principles of professionalism and responsibility.		Are we doing the best we can for the 60 million Europeans living with diabetes? Diabetes is Europe’s silent health pandemic, but is the diagnosis, treatment and management of diabetes getting the focus it deserves?

	Every Day Counts: Improving time to patient access to innovative oncology therapies in Europe For cancer patients, Every Day Counts… but significant differences exist in patient access to innovative oncology therapies in Europe. Accelerating time to patient access will be critical to beat cancer in Europe.		Every Day Counts: Improving time to patient access to innovative oncology therapies in Europe Professor Lieven Annemans explains differences in patient access to innovative oncology treatment and factors influencing it in Europe

Events     05 OCT 2020   What delays access to medicines? Virtual event Join our next debate about the root causes of unavailability of medicines and delays for patients across the EU #QuestionsInspireSolutions... Learn more →       14 OCT 2020   Flu Vaccination as public health measure during COVID-19 Virtual event Save the Date Learn more →

	15 OCT 2020			Are we spending smart in healthcare? Virtual event How can smart spending improve long-term outcomes while keeping the systems sustainable and flexible in order to respond... Learn more →

	26 OCT 2020			NEW DATES - EU Health Summit 2020 Virtual event The EU Health Coalition is delighted to announce the second edition of the EU Health Summit. Learn more →

Our latest publications Every Day Counts: Improving time to patient access to innovative oncology therapies in Europe... 17 July 2020 (Publications) ... Read more →

What we are watching Every day counts: Accelerate access, beat cancer 21 September 2020  (EFPIA virtual event) Read more → Are we doing the best we can for the 60 million Europeans living with diabetes? 18 September 2020  (EFPIA virtual event) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe